MACULAR DEGENERATION, AGE-RELATED, 14
|
disease |
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
|
0 |
|
|
|
Purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
68
|
1
|
0.100 |
None |
|
0 |
|
|
|
Lupus Vulgaris
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
526
|
44
|
0.300 |
strong |
1.000 |
1 |
|
1993 |
1993 |
IGA Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
456
|
130
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Dermatomyositis, Childhood Type
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
62
|
1
|
0.300 |
None |
1.000 |
1 |
|
1987 |
1987 |
Dermatitis, Irritant
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
29
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Lupus Erythematosus
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
558
|
44
|
0.300 |
strong |
1.000 |
1 |
|
1993 |
1993 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Geographic Atrophy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
85
|
81
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.100 |
None |
1.000 |
1 |
2
|
2007 |
2007 |
Exudative age-related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
158
|
109
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Drug-induced neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
41
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Lean body mass
|
phenotype |
|
Clinical Attribute
|
144
|
211
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
168
|
379
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Myeloperoxidase Measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
16
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
von Willebrand's factor (lab test)
|
phenotype |
|
Laboratory Procedure
|
55
|
427
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.100 |
None |
1.000 |
1 |
2
|
2007 |
2007 |